Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 30, Issue 8, Pages 2792-2801
Publisher
FASEB
Online
2016-04-29
DOI
10.1096/fj.201500155r
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- n-3 Fatty acid supplementation and proresolving mediators of inflammation
- (2016) Anne E. Barden et al. CURRENT OPINION IN LIPIDOLOGY
- Determination of ω-6 and ω-3 PUFA metabolites in human urine samples using UPLC/MS/MS
- (2015) Ai Sasaki et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis
- (2015) H. Hasturk et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice
- (2015) Daisuke Akagi et al. FASEB JOURNAL
- Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function
- (2015) Vasundhara Kain et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Effects of Olive Oil on Markers of Inflammation and Endothelial Function—A Systematic Review and Meta-Analysis
- (2015) Lukas Schwingshackl et al. Nutrients
- Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue
- (2014) Romain A. Colas et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Inflammation and its Resolution as Determinants of Acute Coronary Syndromes
- (2014) Peter Libby et al. CIRCULATION RESEARCH
- Resolvin E1 Metabolome in Local Inactivation during Inflammation-Resolution
- (2014) S. Hong et al. JOURNAL OF IMMUNOLOGY
- Rapid Appearance of Resolvin Precursors in Inflammatory Exudates: Novel Mechanisms in Resolution
- (2014) K. Kasuga et al. JOURNAL OF IMMUNOLOGY
- Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation
- (2014) Anne Barden et al. JOURNAL OF LIPID RESEARCH
- Pro-resolving lipid mediators are leads for resolution physiology
- (2014) Charles N. Serhan NATURE
- The Pro-Resolving Lipid Mediator Maresin 1 (MaR1) Attenuates Inflammatory Signaling Pathways in Vascular Smooth Muscle and Endothelial Cells
- (2014) Anuran Chatterjee et al. PLoS One
- Plasma Phospholipid Long-Chain ω-3 Fatty Acids and Total and Cause-Specific Mortality in Older Adults
- (2013) Dariush Mozaffarian et al. ANNALS OF INTERNAL MEDICINE
- Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, double blind, placebo controlled trials
- (2013) Manuela Casula et al. ATHEROSCLEROSIS SUPPLEMENTS
- D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury
- (2013) Takuya Miyahara et al. FASEB JOURNAL
- Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities
- (2013) I. Tabas et al. SCIENCE
- Circulating and Dietary Omega‐3 and Omega‐6 Polyunsaturated Fatty Acids and Incidence of CVD in the Multi‐Ethnic Study of Atherosclerosis
- (2013) Marcia C. de Oliveira Otto et al. Journal of the American Heart Association
- Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: A potentially protective mechanism in atherosclerotic vascular disease and cancer
- (2012) Egeria Scoditti et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Omega-3 Polyunsaturated Fatty Acids and the Treatment of Rheumatoid Arthritis: A Meta-analysis
- (2012) Young-Ho Lee et al. ARCHIVES OF MEDICAL RESEARCH
- Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators
- (2012) J. Dalli et al. BLOOD
- Resolvins D1, D2, and Other Mediators of Self-Limited Resolution of Inflammation in Human Blood following n-3 Fatty Acid Supplementation
- (2012) E. Mas et al. CLINICAL CHEMISTRY
- Role of Basic Science in the Development of New Medicines: Examples from the Eicosanoid Field
- (2012) Bengt Samuelsson JOURNAL OF BIOLOGICAL CHEMISTRY
- n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Impact of omega-3 polyunsaturated fatty acids on coronary plaque instability: An integrated backscatter intravascular ultrasound study
- (2011) Tetsuya Amano et al. ATHEROSCLEROSIS
- Lipoxygenase and Leukotriene Pathways: Biochemistry, Biology, and Roles in Disease
- (2011) Jesper Z. Haeggström et al. CHEMICAL REVIEWS
- n–3 Fatty Acids in Cardiovascular Disease
- (2011) Raffaele De Caterina NEW ENGLAND JOURNAL OF MEDICINE
- The Human Serum Metabolome
- (2011) Nikolaos Psychogios et al. PLoS One
- Impaired Phagocytosis in Localized Aggressive Periodontitis: Rescue by Resolvin E1
- (2011) Gabrielle Fredman et al. PLoS One
- Aspirin-Triggered Lipoxin and Resolvin E1 Modulate Vascular Smooth Muscle Phenotype and Correlate with Peripheral Atherosclerosis
- (2010) Karen J. Ho et al. AMERICAN JOURNAL OF PATHOLOGY
- Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets
- (2008) M. Dona et al. BLOOD
- Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators
- (2008) Aksam J. Merched et al. FASEB JOURNAL
- A near null variant of 12/15-LOX encoded by a novel SNP in ALOX15 and the risk of coronary artery disease
- (2007) Themistocles L. Assimes et al. ATHEROSCLEROSIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started